Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab
This clinical trial update describes using transcriptomics to guide ustekinumab treatment for Ulcerative Colitis. The study has completed, w…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment [Phase 2]
A Phase 2 study evaluating tacrolimus lipid suspension delivered as an enema for adults with mild to moderately active left-sided/distal ulc…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative Colitis [NA]
This clinical trial is evaluating multi-strain probiotic supplementation as an adjunct to standard care for mild to moderate ulcerative coli…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation
A completed clinical trial assessing changes in Faecal Calprotectin levels and participation-related scores after three weeks of inpatient r…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Psychological Intervention for Fatigue in Inflammatory Bowel Diseases [NA]
A clinical trial is evaluating a psychological intervention to reduce fatigue in inflammatory bowel disease, including Crohn's disease and u…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis
A clinical trial evaluating Maresin-1 and Resolvin-D1 levels and disease activity in Ulcerative Colitis has completed.
-
FDA approval · 2025-03-06FDA Approved: MESALAMINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Mesalamine submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.
An observational multicenter study sponsored by Meyer Children's Hospital IRCCS is recruiting to examine eating habits and their association…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis [Phase 2]
This Phase 2 study evaluated the long-term safety and efficacy of ABX464 in active ulcerative colitis and has completed with results posted …
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease [Phase 1, Phase 2]
Phase 1 and Phase 2 clinical trials are exploring fluorescence imaging with Risankizumab-800CW in inflammatory bowel disease, including ulce…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) [Phase 2]
Phase 2a trial update for PL-8177 in subjects with active Ulcerative Colitis; the study is currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Beneficial Effect of Silymarin in Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating the beneficial effect of silymarin in Ulcerative Colitis is currently recruiting. Sponsored by Tanta Uni…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium
A clinical trial update on the study assessing treatment patterns and outcomes with upadacitinib in adults with inflammatory bowel disease i…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: the Long-term Retention Rate and Influence Factors of Individualized Treatment of Vedolizumab in Ulcerative Colitis
This update reports on the long-term retention rate of Vedolizumab for ulcerative colitis and examines factors that influence its ongoing us…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease
The trial update reports the completed study evaluating the risk of drug exposure to infants breastfed by women with inflammatory bowel dise…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: An Exploration of the Relationship Between Serum Cytokine Levels and the Clinical Efficacy of Vedolizumab
A completed clinical trial exploring the relationship between serum cytokine levels and Vedolizumab's clinical efficacy in ulcerative coliti…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Metformin as Added on Therapy in Patients With Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial is evaluating adding metformin to standard therapy for ulcerative colitis and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis. [Phase 2]
Phase 2 clinical trial evaluating pentoxifylline as an adjunctive therapy for ulcerative colitis, currently recruiting at Tanta University.
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
Clinical trial update on high-dose, interval Vitamin D supplementation for patients with inflammatory bowel disease on biologic therapy; rec…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
This is an observational real-world study to assess changes in disease activity and adverse events in adults with moderate to severe ulcerat…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease [NA]
A recruiting clinical trial evaluating proactive infliximab monitoring and optimization in inflammatory bowel disease, including Crohn's dis…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Personalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of the Presager Project
This entry describes a recruiting clinical trial at Copenhagen University Hospital focusing on predicting the disease course of Ulcerative C…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: The Contact Activation System and Ulcerative Colitis
A completed clinical trial studying the involvement of the contact activation system in ulcerative colitis at Esbjerg Hospital – University …
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Whey Protein Milk-Derived Exosomes [NA]
This update notes a clinical trial evaluating whey protein milk-derived exosomes for ulcerative colitis and inflammatory bowel disease, with…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: GI Permeability Change in Response to Aquamin® [Phase 2]
Phase 2 trial evaluating the effect of Aquamin on gastrointestinal permeability in Ulcerative Colitis patients, Irritable Bowel Syndrome wit…